Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Enzyme formulation for pancreatic insufficiency enters preclinical development at Altus

Nov. 5, 1998

Zadaxin plus famciclovir provides surprising synergistic efficacy against HBV

Nov. 5, 1998

Chiron pinpoints site of HCV binding to host cells

Nov. 2, 1998

Intranasal delivery of CpG DNA with HBsAg stimulates both systemic and mucosal immunity

Oct. 30, 1998

Prostaglandin analogues attenuate ischemic liver damage in canine model

Oct. 29, 1998

Medeva seeks E.U. approval for third-generation hepatitis B vaccine

Oct. 28, 1998

Clinical testing of nonantibiotic anti-H. pylori agent will begin; development partner sought

Oct. 27, 1998

Shiseido claims pyrrolidines for gastric and peptic ulcers

Oct. 27, 1998

New study compares balsalazide to mesalamine

Oct. 26, 1998

Benzamides with antiulcer, antisecretory and anti-H. pylori effects discovered at Shiseido

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...